The UK announced the funding at the AI Action Summit in Paris where it abstained from signing a declaration on an inclusive ...

Google parent Alphabet has drawn on its DeepMind artificial intelligence division to form a drug discovery unit that it calls Isomorphic Labs. The UK-registered company will be able to tap into ...

Google parent Alphabet has drawn on its DeepMind artificial intelligence division to form a drug discovery unit that it calls Isomorphic Labs. The UK-registered company will be able to tap into ...

XoZymes replaces traditional chemical production methods with an approach that integrates widely available feedstocks like sugar and biomass with advanced enzymes engineered to thrive outside living ...

His research explores the rise of generative AI and accelerated use of AI more broadly to advance drug and scientific discovery. Reuben leads Gartner's coverage of genomics, multiomics, cell and gene ...

AI creates anti-cancer molecules for proteins that previously could not be targeted pharmacologically by leveraging quantum ...

Access to data and to skills specific to AI are among the key challenges pharma companies face to unlock the technology’s ...

A complementary drug to combat Alzheimer's disease could target a specific part of the nerve cell protein tau. This is the finding of new research which also offers a better way to measure the effect ...

Matt Price drove his 73-year-old father Stephen from their New Jersey home to a medical strip mall on the Jersey Shore, for ...

An AI system developed by Google DeepMind, Google’s leading AI research lab, appears to have surpassed the average gold medalist in solving geometry problems in an international mathematics ...

A landmark study reporting the discovery of Australopithecus africanus one century ago put the African continent at the centre of the story of humanity. Overcrowding can lead to disaster ...